A Pilot Trial of Dextroamphetamine for Methamphetamine Dependence (1D)

California Pacific Medical Center Research Institute

Status and phase: Completed; Phase 2

Conditions: Methamphetamine Addiction

Treatments: Drug: Placebo; Drug: Dextroamphetamine

Study type: Interventional

Funder types: Other

Identifiers

NCT00630682

P50DA018179 (U.S. NIH Grant/Contract)

25.139

Details and patient eligibility

About

The purpose of this study is to assess the safety and effectiveness dextroamphetamine to help methamphetamine users quit or cut down on their use. The study lasts for 9 weeks. Eligible participants will attend research visits twice per week, and will receive individual counseling sessions once per week for all 9 weeks. 50% of the participants will receive the active medication while the other 50% will receive the placebo (sugar pill). Neither the participant or the study team will know if the participant is receiving the placebo or active drug.

Enrollment: 60 patients

Sex: All

Ages: 18 to 50 years old

Volunteers: No Healthy Volunteers

Inclusion criteria

• 18-50 yrs. old

Exclusion criteria

• pregnant or lactating females

  • Contact site for additional information

Trial design

Primary purpose: Treatment

Allocation: Randomized

Interventional model: Parallel Assignment

Masking: Triple Blind

---

60 participants in 2 patient groups, including a placebo group

Dextroamphetamine

Active Comparator group

Description:

Active drug

Treatment:

Drug: Dextroamphetamine

Placebo

Placebo Comparator group

Description:

Placebo of drug

Treatment:

Drug: Placebo